Go the Distance When Treating Otitis Media
When it comes to treating otitis media in children, longer is better, according to a new study. Researchers designed a trial to determine if five days of amoxicillin-clavulanate was non-inferior to 10 days, with the assumption that a shorter course would reduce the risk of antibiotic resistance. Researchers assigned 520 children 6-23 months of age with acute otitis media for a standard duration of 10 days or a reduced duration of five days followed by placebo for 5 days. The clinical failure rate was 34% in the shorter duration group vs. 16% for standard duration (95% confidence interval, 9-25). The mean symptom scores also were higher in the shorter duration group. There was no difference in adverse events or nasopharyngeal colonization with penicillin- nonsusceptible pathogens. The authors concluded that reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment. Additionally, neither the rate of adverse events nor the rate of emergence of antimicrobial resistance was lower with the shorter regimen (N Engl J Med 2016;375:2446-2456).
A recent study revealed that reduced-duration antimicrobial treatment resulted in less favorable outcomes than standard-duration treatment.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.